KOL Perspectives: Perceptions of Lupus Pipeline Therapy Data Presented at EULAR 2018

KOL Perspectives: Perceptions of Lupus Pipeline Therapy Data Presented at EULAR 2018


This KOL Insight briefing focuses on KOLs views of Pipeline Therapy Data Presented at EULAR 2018.

Questions topics -

  • Opinion on abatacept failing to achieve its primary endpoint in its Phase III LN trial
  • Views on the Phase III safety data for abatacept in LN
  • Expectations regarding abatacept’s future development in lupus
  • Opinion on ustekinumab’s ability to achieve partial improvements using SLEDAI-2K Responder Index-50
  • Views on ustekinumab’s Phase III trial design
  • Views on the absence of safety endpoints in the Phase III ustekinumab trial in SLE
  • Perception of etanercept’s efficacy in discoid lupus erythematosus
  • Opinion on etanercept’s safety data from the Phase II TARGET-DLE trial
Key Highlights
  • While most KOLs agreed that abatacept’s future in LN is uncertain, half of the KOLs highlighted that the drug has potential in lupus arthritis
  • Most KOLs highlighted that SLEDAI-2K Responder Index-50 data supports ustekinumab use in SLE
  • While most KOLs flagged that etanercept may exacerbate lupus features, half of the KOLs highlighted that etanercept has potential in lupus.
  • The insight briefing is based on Sociable Pharma’s analysis of primary research with our Lupus key opinion leaders (KOLs).
In total, we conducted interviews with 10 KOLs -
  • 5 Europe-based & 5 N. America-based
  • Interviews performed during Aug 2018
KOL data is analyzed to produce -
  • Charts summarizing KOL opinions
  • Chart call-outs of key information & details
  • KOL quotes
  • Summary of KOL reporting trends
  • Insight from Sociable Pharma's analysts
Reasons to buy
  • Combines Qualitative & semi-quantitative insight from key opinion leaders on Pipeline Therapy Data Presented at EULAR 2018
  • Includes insight & recommendations from our disease-specific healthcare analysts
  • Utilizes independent expert viewpoints to validate the impact of new clinical data & emerging trends on management of Lupus
  • Provides cost-effective support for your advisory boards, with topics acting as a catalyst for further expert discussion.

Executive Summary
Research Panel Composition
Results & Implications

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook